热门资讯> 正文

Kodiak Sciences GAAP每股收益为-1.04美元

2026-04-01 04:49

Kodiak Sciences(KOD) 0

Kodiak Sciences press release (KOD): Q4 GAAP EPS of -$1.04 in-line.
Kodiak ended 2025 with $209.9 million of cash and cash equivalents. The firm believes that its current cash and cash equivalents will support its current and planned operations into 2027.

More on Kodiak Sciences

Kodiak Sciences: Shares Up On Positive Eye Disease Data - But I Remain On Sidelines
Kodiak Sciences Inc. (KOD) Presents at Angiogenesis, Exudation, and Degeneration 2026 - Slideshow
Kodiak Sciences: A Stellar Move
Kodiak climbs on late-stage trial win for diabetic retinopathy therapy
Seeking Alpha’s Quant Rating on Kodiak Sciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。